Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Aug 2019 07:00

Arix Bioscience Plc - Total Voting Rights

Arix Bioscience Plc - Total Voting Rights

PR Newswire

London, July 31

Arix Bioscience plc: Total Voting Rights

Pursuant to DTR 5.6.1 of the Disclosure Guidance and Transparency Rules:

As at 31 July 2019, Arix Bioscience plc had 135,551,850 Ordinary Shares of £0.00001 each in issue. There were no shares held in treasury.

The total number of voting rights in Arix Bioscience plc is therefore 135,551,850.

This information may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, Arix Bioscience plc under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Arix Bioscience plc

Robert Lyne, Company Secretary 0207 290 1055

Date   Source Headline
11th Dec 20197:05 amPRNIterum announces topline Phase 3 data
9th Dec 20197:01 amPRNAutolus announces new AUTO3 data at ASH
9th Dec 20197:00 amPRNAutolus announces key new data at ASH
22nd Nov 20199:57 amPRNHolding(s) in Company
21st Nov 201912:06 pmPRNHarpoon and AbbVie announce licensing and option deal
7th Nov 201912:22 pmPRNAutolus reports Q3 2019 financial results
7th Nov 20197:22 amPRNChange of Broker
6th Nov 20192:31 pmPRNAutolus to present new data at the ASH Annual Meeting
6th Nov 20197:02 amPRNArtios expands DDR pipeline with new asset
17th Oct 20191:40 pmPRNHolding(s) in Company
16th Oct 20198:00 amPRNAura reports updated Phase 1b/2 clinical data for AU-011
15th Oct 20193:20 pmPRN]Holding(s) in Company
3rd Oct 20197:06 amPRN2019 Capital Markets Day
2nd Oct 20197:00 amPRNManagement change
30th Sep 20197:00 amPRNArix co-leads EUR 20m Series A financing in STipe
17th Sep 20197:47 amPRNAmplyx unveils expanded pipeline and Phase 2 data
28th Aug 20197:00 amPRNInterim results for the six months ended 30 June 2019
20th Aug 20197:25 amPRNNotice of Results
8th Aug 20191:03 pmPRNAutolus reports Q2 2019 financial results
1st Aug 20197:00 amPRNTotal Voting Rights
8th Jul 20193:34 pmPRNHolding(s) in Company
3rd Jul 20197:00 amPRNIssue of Ordinary Shares, TVR, PDMR Notifications
28th Jun 20193:22 pmPRNHolding(s) in Company
25th Jun 20194:17 pmPRNHolding(s) in Company
18th Jun 20195:23 pmPRNHolding(s) in Company
3rd Jun 20195:51 pmPRNCorrection: Result of AGM
3rd Jun 20195:16 pmPRNResult of AGM
3rd Jun 20197:00 amPRNTotal Voting Rights
10th May 20197:00 amPRNDirector/PDMR Shareholding
1st May 20197:00 amPRNIssue of Ordinary Shares and Total Voting Rights
16th Apr 20197:00 amPRNAutolus announces closing of public offering
11th Apr 20197:00 amPRNAutolus announces pricing of public offering
9th Apr 20197:00 amPRNAutolus announces launch of proposed public offering
2nd Apr 20197:08 amPRNAura completes $40 million Series D financing
1st Apr 20196:10 pmPRNAutolus presents initial AUTO1 data at AACR
28th Mar 20197:00 amPRNAnnual Results for the year ended 31 December 2018
28th Mar 20197:00 amPRNBoard changes
26th Mar 201910:17 amPRNAutolus hosts R&D day and provides update on AUTO3
20th Mar 201912:23 pmPRNNotice of Results
18th Mar 20197:00 amPRNArix co-leads $63m Series B investment round for Imara
19th Feb 201912:12 pmPRNAutolus announces updated results from CARPALL trial
19th Feb 20197:00 amPRNManagement and Board changes
14th Feb 20197:00 amPRNHarpoon closes initial public offering
8th Feb 20197:09 amPRNHarpoon prices Nasdaq IPO
1st Feb 201910:38 amPRNTotal Voting Rights
29th Jan 20192:25 pmPRNUpdate on Harpoon proposed IPO in the United States
3rd Jan 20197:00 amPRNIssue of Ordinary Shares and Total Voting Rights
28th Dec 20187:00 amPRNHarpoon announces proposed public offering in the US
11th Dec 20187:00 amPRNArix appoints Dr Christian Schetter as EIR
3rd Dec 20187:00 amPRNAutolus presents initial AUTO3 clinical data at ASH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.